Quincy Bioscience Launches New National Advertisement in USA Today

MADISON, Wis. - Oct. 28, 2013 - PRLog -- Quincy Bioscience, a Wisconsin-based biotech company, announces the launch of a new national advertisement in the USA Today newspaper to promote the nation’s leading memory supplement known as Prevagen®.

The USA Today ad features Prevagen’s position as the No. 1 selling branded memory supplement in chain drug stores in the country. Prevagen is the first apoaequorin-based product developed by Quincy Bioscience. This unique brain health supplement has been clinically shown to improve memory, focus and concentration. The Prevagen campaign also includes social media (http://www.facebook.com/prevagen) and television advertising.

With the baby boomer generation including over 70 million Americans who are living longer than any preceding generation, the demand for products which preserve and promote health is rising.

“Mild memory loss associated with aging is the number one cause of memory decline in our country today,” said Mark Underwood, President and co-founder of Quincy Bioscience. “While it can start with innocent issues like losing your cell phone or your car keys, it can get scary as we grow older. Our goal is to address memory loss with a preventative approach to brain health, and our research has demonstrated that Prevagen is a safe and effective product for assisting with this type of memory loss.”

In 2012, Prevagen became the nation's leading brain health supplement in chain drug stores across the country, and continues to remain on top. Prevagen is available in health food stores and pharmacies nationwide including Walgreens, CVS, Rite Aid, and Vitamin Shoppe.

The Prevagen campaign shares a successful approach for individuals to reduce mild memory loss issues associated with aging. Learn more about Prevagen at www.prevagen.com.

About Quincy Bioscience
Quincy Bioscience (http://www.quincybioscience.com/) is a biotechnology company based in Madison, Wis. that focuses on the discovery, development and commercialization of novel technologies to support good health in aging. The company’s products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.